Serum neurofilament light chain (sNFL) as a predictive biomarker for Chemotherapy-induced peripheral neurotoxicity (CIPN): consideration of current evidence, validation steps, and barriers to CIPN biomarker implementation in clinical practice—a narrative review
- DOI
- 10.1007/s00520-026-10690-2
- Published
- 2026-05-07
- Container
- Supportive Care in Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00520-026-10690-2,
title = {Serum neurofilament light chain (sNFL) as a predictive biomarker for Chemotherapy-induced peripheral neurotoxicity (CIPN): consideration of current evidence, validation steps, and barriers to CIPN biomarker implementation in clinical practice—a narrative review},
author = {Paola Alberti and Sara Faithfull and Andreas A. Argyriou and David Balayssac and Daniel L. Hertz and Maryam Lustberg and Susanna B. Park and Tiffany Li and Mary Tanay and Terri Jabaley and Lise Worthen-Chaudhari and Ellen M. L. Smith and Unknown},
year = {2026},
journal = {Supportive Care in Cancer},
doi = {10.1007/s00520-026-10690-2},
url = {https://doi.org/10.1007/s00520-026-10690-2}
}RIS
TY - JOUR TI - Serum neurofilament light chain (sNFL) as a predictive biomarker for Chemotherapy-induced peripheral neurotoxicity (CIPN): consideration of current evidence, validation steps, and barriers to CIPN biomarker implementation in clinical practice—a narrative review AU - Paola Alberti AU - Sara Faithfull AU - Andreas A. Argyriou AU - David Balayssac AU - Daniel L. Hertz AU - Maryam Lustberg AU - Susanna B. Park AU - Tiffany Li AU - Mary Tanay AU - Terri Jabaley AU - Lise Worthen-Chaudhari AU - Ellen M. L. Smith AU - Unknown PY - 2026 JO - Supportive Care in Cancer DO - 10.1007/s00520-026-10690-2 UR - https://doi.org/10.1007/s00520-026-10690-2 ER -
APA
Alberti, P., Faithfull, S., Argyriou, A. A., Balayssac, D., Hertz, D. L., Lustberg, M., Park, S. B., Li, T., Tanay, M., Jabaley, T., Worthen-Chaudhari, L., Smith, E. M. L., & Unknown (2026). Serum neurofilament light chain (sNFL) as a predictive biomarker for Chemotherapy-induced peripheral neurotoxicity (CIPN): consideration of current evidence, validation steps, and barriers to CIPN biomarker implementation in clinical practice—a narrative review. Supportive Care in Cancer. https://doi.org/10.1007/s00520-026-10690-2
Source records
- crossref · retrieved 2026-11-10T15:53:58.936Z